Publication | Closed Access
OXI 4503 a novel vascular targeting agent: Effects on bloodflow and antitumor activity in comparison to Combretastatin A-4 phosphate
67
Citations
0
References
2002
Year
OncologyAngiogenesisMedicineVascular PharmacologyCombretastatin A-4 PhosphateVascular BiologyPharmacotherapyNovel VascularTumor TargetingAnti-cancer AgentPharmacologyCell BiologyTumor MicroenvironmentCancer ResearchOxi 4503
No additional data available for this publication yet. Check back later!